Abstract
Following the introduction of an efficient method for the preparation of technetium-99m complexes containing a terminal Tc-N multiple bond, under conditions suitable for nuclear medicine applications, new radiopharmaceuticals for heart and brain imaging have been discovered. These compounds belong to the class of bi-substituted, square-pyramidal nitride TcV complexes with dithiocarbamate ligands, and are the first examples of radiopharmaceuticals of this type exhibiting interesting biological properties. The peculiar chemical characteristics of the Tc-N core can also be conveniently utilized for the design of radiopharmaceuticals incorporating bioactive peptides and having definite structural features.
Similar content being viewed by others
References
K. Dehnicke and J. Strähle, Angew. Chem., Int. Engl. Ed., 31, 955 (1992).
A. Duatti, A. Marchi and R. Pasqualini, J. Chem. Soc., Dalton Trans., 3729 (1990).
R. Pasqualini, V. Comazzi, E. Bellande, A. Duatti and A. Marchi, Appl. Radiat. Isot., 43, 1329 (1992).
R. Pasqualini and A. Duatti, J. Chem. Soc., Chem. Commun., 1354 (1992).
R. Pasqualini, A. Duatti, E. Bellande, V. Comazzi, V. Brucato, D. Hoffschir, D. Fagret and M. Comet, J. Nucl. Med., 35, 334 (1994).
L. Uccelli, M. Giganti, A. Duatti, C. Bolzati, R. Pasqualini, C. Cittanti, P. Colamussi and A. Piffanelli, J. Nucl. Med., 36, 2075 (1995).
A. Duatti and L. Uccelli, Trends Inorg. Chem., 4, 27, (1996).
C. Bolzati, A. Duatti, L. Uccelli and G. Zucchini, unpublished observations.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Duatti, A., Bolzati, C., Uccelli, L. et al. Technetium-99m nitride radiopharmaceuticals. Transition Metal Chemistry 22, 313–314 (1997). https://doi.org/10.1023/A:1018489113564
Published:
Issue Date:
DOI: https://doi.org/10.1023/A:1018489113564